Grace Therapeutics (GRCE) Institutional Ownership $2.97 +0.01 (+0.34%) As of 03:18 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Grace Therapeutics (NASDAQ:GRCE)CurrentInstitutional OwnershipPercentage6.08%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$4.14MNumber ofInstitutional Sellers(last 12 months)0 Get GRCE Insider Trade Alerts Want to know when executives and insiders are buying or selling Grace Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Grace Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025 ADAR1 Capital Management LLC343,512$783K0.1%N/A3.388% 5/15/2025 Nantahala Capital Management LLC1,178,203$2.69M0.1%N/A11.619% 5/14/2025 Stonepine Capital Management LLC294,550$666K0.6%N/A2.905% (Data available from 1/1/2016 forward) GRCE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GRCE shares? During the previous two years, the following institutional investors and hedge funds held shares of Grace Therapeutics shares: Nantahala Capital Management LLC ($2.69M), and ADAR1 Capital Management LLC ($783K), Stonepine Capital Management LLC ($666K).Learn more on GRCE's institutional investors. What percentage of Grace Therapeutics stock is owned by institutional investors? 6.08% of Grace Therapeutics stock is owned by institutional investors. Learn more on GRCE's institutional investor holdings. Which institutional investors have been buying Grace Therapeutics stock? The following institutional investors have purchased Grace Therapeutics stock in the last 24 months: Nantahala Capital Management LLC ($1.18M), ADAR1 Capital Management LLC ($343.51K), and Stonepine Capital Management LLC ($294.55K). How much institutional buying is happening at Grace Therapeutics? Institutional investors have bought a total of 1,816,265 shares in the last 24 months. This purchase volume represents approximately $4.14M in transactions. Related Companies Korro Bio Major Shareholders Cardiol Therapeutics Major Shareholders BioHarvest Sciences Major Shareholders Atossa Therapeutics Major Shareholders Invivyd Major Shareholders Cabaletta Bio Major Shareholders Lexeo Therapeutics Major Shareholders Corbus Pharmaceuticals Major Shareholders Contineum Therapeutics Major Shareholders Procaps Group Major Shareholders This page (NASDAQ:GRCE) was last updated on 6/6/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Wealth Reset: Could You Be The First Beneficiary?Trump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major shift is coming this July — and Wall Street isn't waiting around. Thanks to a new rule going into e...American Alternative | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredHow to target 627% gains from Trump’s tweetsPresident Trump is shaking up the market with his tweets and Truth Social posts... But while this chaos has...Monument Traders Alliance | SponsoredThe Age of Chaos has begunThis is one of the most confusing markets in history. We have entered an Age of Chaos. And you must take...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Grace Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Grace Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
